Pulmonary morphometric histopathology of saline or paraquat-exposed rats treated with the collagen inhibitor dehydroproline by Onyeama, Henry Patrick.
PULMONARY MORPHOMETRIC HISTOPATHOLOGY OF SALINE OR PARAQUAT-EXPOSED
RATS TREATED WITH THE COLLAGEN INHIBITOR DEHYDROPROLINE
by
HENRY PATRICK ONYEAMA
D.V.M., Univei^sity of Ibadan, Nigeria, 1977
A MASTER'S THESIS
submitted in partial fulfillment of the
requirements for the degree
MASTER OF SCIENCE
Department of Surgery and Medicine
KANSAS STATE UNIVERSITY
Manhattan, Kansas
1984
Approved by:
J.
Major Professor
6. %-
A112D5 b7266a
DEDICATION
To my friend, Dima Hamarneh,
TABLE OF CONTENTS
Page
ACKNOWLEDGMENTS i
INTRODUCTION i i
LITERATURE CITED vi
PULMONARY MORPHOMETRIC HISTOPATHOLOGY OF SALINE
OR PARAQUAT-EXPOSED RATS TREATED WITH
COLLAGEN INHIBITOR DEHYDROPROLINE 1
Key Words 2
Summary 4
Introduction 6
Material s and Methods 7
Resul ts 11
Statistical Analysis 11
Discussion 13
References 19
Tables 21
Figures 23
APPENDIX I: A LITERATURE REVIEW OF PARAQUAT
AND RELATED CHEMICAL TOXICITIES 30
References 53
Figures 58
APPENDIX II: TREATMENT OF RATS WITH PARAQUAT
AND/OR THE COLLAGEN INHIBITORS
L-3,4-DEHYDR0PR0LINE (L-DHP) AND
DL-3 ,4-DEHYDROPROLINE (DL-DHP) 61
Page
APPENDIX III: INDIVIDUAL RESULTS OF RAT LUNG
MORPHOMETRIC MEASUREMENTS 66
Measurements 76
ABSTRACT
ACKNOWLEDGMENTS
I express my gratitude to Dr. F.W. Oehme, my major professor,
for his constant guidance and encouragement during the course of
this investigation and for his advice in the preparation of this
manuscript. The useful suggestions and personal guidance by
Dr. R.D. Klemm and his magniminity in putting the facilities in his
laboratory at my disposal, are gratefully acknowledged. Great
thanks are due to Mike Deaton for his statistical analysis of the
morphometric data and, also to Dr. R.K. Burkhard and Dr. P. Schoning,
committee members, for reviewing this write-up. I also wish to ex-
press my thanks to Dr. M.R. Fedde for his wonderful references on
morphometry of the lungs.
I am deeply indebted to National Veterinary Research Institute,
Vom, Jos, Nigeria, for the financial support in my study.
I extend, finally, my appreciation to my mum, dad and brother,
John for their moral support during the course of this study.
INTRODUCTION
Paraquat is a non-selective herbicide. The basic chemical
nucleus of paraquat is a bipyridyl consisting of two pyridine rings
joined together in such a way that their nitrogen atoms face dia-
metrically away from each other (Fig 1). Hence, paraquat is a
quaternary bipyridyl. Since each nitrogen atom bears a methyl group
side chain in the para position (Fig 2), the chemical is therefore,
a PARA-substituted QUATernary bipyridyl --hence the common designation
PARAQUAT (1). Other closely related analogues of paraquat are diquat
(l,r-ethylene-2,2'-dipyridylium dibromide) (Fig 3) and morfamquat
(l,r-(3,5'-dimethylmorpholinocarbonyl)-4,4'-dipyridilium di chloride)
(Fig 4).
In many countries where paraquat has been used as a herbicide,
deaths of many people have been reported and associated with their
exposure to paraquat. The most devastating effect of paraquat poison-
ing occurs in the lungs where it initially trigers exudation of edema
fluid and hemorrhages into the lungs parenchyma (2). If the victim
survives these initial effects, a fulminating fibrotic process
develops (2) and death results from anoxia due to progressive pulmonary
fibrosis. The toxic manifestations and processes appear to be similar
in almost all animals including man. Extensive necrosis of the pul-
pulmonary alveolar epithelium with the attendant inflammatory changes
has been known to be caused by paraquat (3), but the resulting inter-
stitial fibrosis of the lungs has not been seen in rabbits and
n
'-V-V-'IJ*'**.,
guinea-pigs (4,5). This may suggest resistance of these experimental
animals to experimentally-induced paraquat poisoning.
Paraquat has been shown to function as a redox agent and con-
tributes to the formation of an oxygen free radical (6,7). Paraquat
causes lipid peroxidation v/hich damages cell structure and function
by destroying the membranes of the mitochondria, microsomes and other
subcellular organelles. Since it is generally accepted that the
action of paraquat as a herbicide is most likely due to lipid peroxi-
dation, many experiments have been carried out to determine the
effectiveness of free radical scavengers and anti -inflammatory agents
(2,8), superoxide dismutase (9,10) and vitamin E (6) as prophylactic
or therapeutic agents in the treatment of paraquat intoxication.
However, their use has not been clinically effective in spite of the
fact that they seemed to have protective effects in experimental
studies (2,6,11). There is no therapeutic agent presently known to
have an antidotal effect in paraquat poisoning.
Paraquat-poisoned rats have increased levels of hydroxyproline,
increased prolyl -hydroxylase and transglutaminase activity in the
lungs (12), and an increased rate of collagen synthesis (10,13).
These increases in enzyme activity and collagen synthesis correspond
to the early histological appearance of cellular proliferation in the
lung alveoli (14).
The proline analogue dehydroproline (DHP) inhibits the biosyn-
thesis and secretion of collagen (15). Of the several proline
analogues tested in vitro , DHP is the most potent inhibitor of
m
aminoacylation reactions, particularly the aminoacylation of *
prolyl-t-RNA (15). Dehydroproline is a competitive inhibitor which
can serve as substrate in this aminoacylation reaction. The admini-
stration of DHP also inhibits prolyl -hydroxylase activity (16), and
although the exact mechanism is not certain, DHP can form stable
complexes with prolyl -hydroxylase in vitro (17). In addition to its
effects on biosynthesis, DHP has been shown to inhibit the secretion
of both tropoelastin and collagen (18). However, no studies have been
found on the ability of DHP to inhibit the elevated enzyme activities
which occur following acute lung injury.
This project investigates the effectiveness of L-3,4-dehydroproline
(L-DHP) and DL-3,4-dehydroprol ine (DL-DHP) as therapeutic agents for
treating lungs from paraquat-exposed rats by comparing the degree of
fibrosis and consolidation of the lung parenchyma in rats that received
saline/saline or paraquat/saline to those that received paraquat/L-DHP
or paraquat/DL-DHP. The reaction of paraquat intoxication in man and
domestic animals is similar to that seen in rats in which the oral
LDr^ to paraquat is 150 mg/kg weight.
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Summary
Exposure to the herbicide paraquat has caused animal and human
deaths due to pulmonary edema, hemorrhage, increased collagen syn-
thesis and progressive pulmonary fibrosis. Because dehydroproline
(DHP) inhibits the biosynthesis of collagen, its value as an anti-
dote for paraquat poisoning was studied in rats.
In a previous study, subcutaneous administration of 7 mg
paraquat/kg body weight for 7-8 days caused early pulmonary fibrosis
and a decrease in body weight 1-10 days after paraquat dosing was
started. L-3,4-dehydroproline, DL-3,4-dehydroproline or saline was
then administered to three randomized groups of the paraquat-dosed
rats at 25 mg/kg body weight for 14 days (days 11-24). One group of
rats that earlier recieved no paraquat, but only saline, was treated
with saline as a negative control group. Representative number of
rats for each group were sacrificed on days 10, 18, 25, 32, 39 and 100.
Lung tissue from this experiment was collected and fixed in formalin
for morphometric histopathological measurements. The following
parameters were quantitated by light microscopy: number of intra-
alveolar macrophages and leucocytes/fibroblasts, total number of
pulmonary cells, mean alveolar wall thickness, percent consolidation
of lung parenchyma and the relative number of various alveolar cell
types (types I and II pneumocytes). The results were compared between
the various groups using analysis of variance.
Dehydroproline significantly reduced the number of pulmonary
cells, especially the number of intra-alveolar macrophages. If
stimulation of fibroblastic activity is through the medium of macro-
hage numbers, DHP decreased the lung response to paraquat exposure.
However, the administered DHP did not significantly reduce the
accompanying pulmonary fibrosis or consolidation.
Introduction
Paraquat dichloride (Fig 1) causes a fulminating fibrotic
process in the lungs; death occurs in several days from anoxia due
1 2
to the progressive pulmonary fibrosis. ' Initially, exudation of
edema fluid and hemorrhages occur in the lung parenchyma. Paraquat
is a redox agent and contributes to the formation of oxygen free
radicals. ' These radicals cause lipid peroxidation which damages
3
cell membranes and subcellular organelles. Although many
experiments have studied the effectiveness of free radical scavengers
as prophylactic or therapeutic agents for paraquat intoxication, their
5
clinical use has not been effective.
Additional efforts have been made using biochemical and morpho-
logical approaches to evaluate the primary damage due to paraquat and
devise an effective treatment. ''' Paraquat-poisoned rats have
increased lung levels of hydroxyproline and prolyl -hydroxylase and an
increased rate of collagen synthesis, leading to pulmonary fibrosis.
The proline analogue, dehydroproline (DHP), inhibits the biosynthesis
and secretion of collagen by competitively blocking the aminoacylation
of t-RNA by proline; DHP also inhibits prolyl -hydroxylase
activity. ' Because of these inhibitory effects on lung collagen bio-
synthesis, DHP was studied as a possible therapeutic agent for experi-
mental paraquat poisoning in rats. Specifically, the effectiveness of
the proline analogues L-3,4-dehydroproline (L-DHP) and DL-3,4-
dehydroproline (DL-DHP) was examined.
In a preliminary study, it was determined that the subcutaneous
administration of 7 mg paraquat dichloride/kg body weight for 7-8 days
initiated lung damage appropriate for the study of biochemical lung
changes. Paraquat-exposed rats were then treated with either saline
or 25 mg DHP/kg body weight for 14 days. Representative numbers of
rats from each group were then sacrificed periodically for up to
100 days, and the protein and collagen content of the lungs were
determined. No significant difference in collagen deposition was found
in the lungs of rats treated with saline versus those treated with DHP.
To further study the effect of DHP on the lung reactions in
paraquat-exposed rats, morphometric histopathological measurements of
formal inized lung tissues from this experiment were performed under
light microscopy. This report presents the result of those measurements.
Materials and Methods
Animals and drug administration
—
The one hundred and thirty four,
six-week-old male Sprague-Dawley rats in this experiment weighed
between 135-218 g, and were obtained from the Animal Resources Facility
of Kansas State University's College of Veterminary Medicine. After
14 days of observation for acclimation, the rats were matched by weight
and allocated randomly into saline-dosed (n=31) or paraquat-dosed
(n=103) groups. The 31 control (saline-dosed) rats received 1.4 ml/kg
body weight of sterile saline solution and the other 103 rats received
7 mg paraquat dichloride^/kg body weight for 7 or 8 days (Fig 2). All
treatments were given subcutaneously. Ten days after the start of
paraquat dosing (day 10), the paraquat-dosed group of rats were divided
randomly into three groups to receive L-DHP (paraquat/L-DHP) or
DL-DHP (paraquat/DL-DHP) or saline (paraquat/saline); 34 rats received
25 mg L-DHP, 34 rats received 25 mg DL-DHP/kg/day, and 35 rats re-
ceived 1.4 ml sterile saline/kg/day, each for 14 consecutive days
(days 11-24) (Fig 2). The saline-dosed group of rats also received
saline injections for days 11-24 (saline/saline).
Collection and preparation of lung tissue- -Rats from the four
groups (saline/saline, paraquat/L-DHP, paraquat/DL-DHP, paraquat/saline)
were sacrificed on days 10, 18, 25, 32, 39 and 100 after the paraquat
dosing was started (Fig 2) to collect lung tissues for morphometric
histopathology. Sacrifice was induced using methoxyflurane (2,2'
Dichloro-l,l-difluroethyl methyl ether) and the rats were drained of
blood via the abdominal arota. The lungs were removed by clasping the
trachea and lifting the organ out. The lungs were then blotted lightly
on a paper towel and the right posterior part of the lobe of the lung
was fixed in 10?^ buffered neutral formalin (BNF). The lung tissues
were sectioned to 6 um thickness and stained with hematoxylin and eosin
(Harris method).
Morphometric measurements of the lung sections--Various morpho-
metric parameters were measured using a Zeiss RA research microscope
with eyepiece micrometer calibration. One division of the eyepiece
micrometer calibration equaled 0.98 um with lOOx objective and 10. Ox
ocular (oil-immersion lens). The area of the field of view of the
oil-immersion lens was calculated using the formula of the surface
2 2
area of a circle, 4nr , or Hd . Using the eyepiece micrometer, the
radius of the field of view was approximately 0.08 mm and the field
2
of view area was calculated to be 0.08 mm . The values obtained for
the various morphometric parameters using this technique were averages
2
from 30 field measurements per parameter for e'^ery 0.08 mm field of
view.
The following parameters were measured:
Number of intra-alveolar macrophages . These macrophages were phago-
cytic cells found within the alveolar spaces and characterized by
rounded appearances of the cells with irregular cytoplasmic membranes.
The nuclei were small but rich in chromatin (heterochromatic) , and
their cytoplasm took on a foamy appearance. For the purpose of this
investigation, epithelioid and giant cells were also considered as
macrophages.
Number of intra-alveolar leucoctyes/fibroblasts . These included white
blood cells involved in the inflammatory response and fibroblasts,
since in paraquat poisoning the offending cells appeared to be pre-
dominantly fibroblasts infiltrating into the alveolar spaces.
Inflammatory leucocytic cells were minimal in number.
Total number of pulmonary cells . This was the summation of the macro-
phages and leucocytes/fibroblasts within the alveolar spaces, but did
not include the alveolar epithelial cells.
Mean alveolar wall thickness (in micrometer, /im) . The alveolar wall
comprised the sparse connective tissue between the basement membranes
of adjacent alveoli
.
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Percentage consolidation of lung parenchyma . This constituted that
part of the lung parenchyma which had become filled with inflammatory
cells, exudates, necrotic epithelial cells and other debris, and was
expressed as a percentage of the lung tissue measured. The percent
consolidation was determined using a microprojector. In this tech-
2
nique the affixed specimen was projected on to a 100 cm white area
background and the percentage of the total lung sample that was con-
12
solidated determined (grid estimation ).
Relative number of cell types (types I and II pneumocytes) in
percentages . The more numerous type I pneumocytes were squamous, and
interspersed between these were the cuboidal type II pneumocytes. Both
of these cell types sat on the alveolar basement membrane. In routine
hematoxylin-eosin stained sections, the basement membrane showed a
thick reticular layer.
The areas measured for all these parameters were randomly selected
alveolar fields. Some of the areas were photographed using Kodak
Panatomic X film.
Statistical analysis- -The data were analyzed by analysis of
variance (ANOVA) using a Statlab Harris 80 Computer with a two-way
treatment structure (treatment and time) in a completely randomized
design. To determine if there was any significant differences between
the paraquat/DL-DHP and the paraquat/saline rats allowed to survive to
day 100 (Fig 2), the group differences in these instances were compared
to a "critical value" (i.e. the value the group differences must exceed
to be of any statistical significance for each parameter under
11
consideration). In all analyses, significant differences were estab-
lished at the p<p.05 level.
Results
Alveolar histopathological impressions- -The lungs and alveolar
structure from the rats in the saline/saline group remained normal
throughout the study (Fig 3). The groups that were exposed to paraquat
had typical paraquat alveolar reactions (Figs 4 and 5) immediately
after the paraquat-exposure period (day 10). This reaction of cellular
infiltration, alveolar wall thickening and lung consolidation increased
in severity with time following the paraquat exposure despite DHP
treatment (Fig 6). The rats that received paraquat and then saline as
a positive control group had especially severely affected lungs that
had extensively thickened alveolar walls and consolidation of the
parenchyma, as well as marked macrophage, leucocyte and fibroblast
infiltration. By day 39 after initiation of the paraquat exposure
these microscopic pathological lesions were severe (Fig 7).
Number of intra-alveolar macrophages --The average number of
intra-alveolar macrophages remained constant in the saline/saline
negative control group and in the paraquat/DL-DHP group, while they
decreased in number in the paraquat group treated with L-DHP and
increased in number in the paraquat positive control group that
received only saline during the treatment period (Table 1). This
trend continued in the paraquat/DL-DHP and paraquat/saline groups
into day 100.
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Number of intra-alveolar leucocytes/fibroblasts—The paraquat/
L-DHP group lung had a significant (p<.0001) decline in the number of
leucocytes and fibroblasts after day 10 when the treatment was given
(Table 1). For instance, there was a decrease from 6 to 3 leucocytes/
0.08 mm^ field of view from day 10 to day 18. The other groups had no
significant changes.
Total number of pulmonary ce11s- -The rats that received paraquat
and then L-DHP had a significant decrease in the total number of pul-
2
monary cells e.g., a decline from 29.6 to 18 cells/0.08 mm from day
10 to 18 (p<.05) compared to the paraquat/saline group, which had an
increase in the number of pulmonary cells from 13.3 to 23 cells/
2
0.08 mm on these days.
Alveolar wall thickness- -No statistically significant difference
existed between the various treatment groups of the paraquat-exposed
animals; all had marked increases in the mean alveolar wall thickness,
when compared to the saline/saline control group (p<.05), that was
not affected by the treatments given.
Percent consolidation of lung parenchyma- -Only the saline/saline
control group differed from the other groups in lung consolidation;
the three paraquat-exposed groups did not differ from one another.
Hence, L-DHP and DL-DHP did not reduce the pulmonary fibrosis result-
ing from paraquat exposure.
Relative numbers of pulmonary epithelial cell types (types I and
11 pneumocytes)- -Al though some fluctuations in type I and type II
pneumocytes numbers occured within and throughout the various groups.
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no statistically significant differences were seen, and no consistent
trends were noted due to various treatments. However, a trend was
present of decreased number of type I pneumocytes and increased number
of type II pneumocytes in the paraquat/saline group versus the L-DHP-
treated group (e.g., an increase from 23.3 to 26.7 during day 10 to 18
in the paraquat/L-DHP group).
Comparison of the paraquat/DL-DHP and paraquat/saline groups from
day 39 to day 100 showed no significant differences between each at
day 39. However, on day 100 the number of macrophages, the number of
pulmonary cells and the alveolar wall thickness of the paraquat/DL-DHP
group were statistically significantly lower than those of the paraquat/
saline group (Table 2).
Discussion
The proline analogs, L-DHP and DL-DHP, which competitively
7 13
inhibit the incorporation of proline into collagen ' were used in
rats to test their potency as treatments for paraquat poisoning.
Since collagen is high in proline content, the replacement of proline
7 13
by L- or DL-DHP will affect collagen metabolism ' by preventing the
aminoacylation of t-RNA by proline, by the reduction of hydroxylation
of prolyl residues, and by the reduction of collagen secretion from
the fibroblasts. However, the inhibitory efficiency of these analogs
had not been demonstrated in vivo .
In the present study, there was no consistent statistically
significant benefit on the pulmonary effects of paraquat toxicity by
L-DHP and DL-DHP treatments when they were administered 10 days after
14
the initial paraquat exposure. Of the several parameters measured,
only the number of intra-alveloar macrophages and the total number of
pulmonary cells had a significant decrease after L-DHP or DL-DHP
treatment when compared to the paraquat/saline group, this corre-
lation is consistent with observations that paraquat stimulates fibro-
14
blasts and that it achieves this through the medium of macrophages,
although the specific nature of this stimulation is unknown. The
origin of infiltrating intra-alveolar profibroblasts (primitive
mesenchymal cells which mature into fibroblasts) is unknown, but it
has been suggested that the profibroblasts derive from primitive
8
histiocyte-like cells which are then transformed into fibroblasts.
The finding that L-DHP significantly reduced the number of intra-
alveolar macrophages supports the beneficial use of these proline
analogs in treating this aspect of in vivo paraquat intoxication.
The absence of significant differences in the number of leuco-
cytes/fibroblasts within and among the various groups suggests failure
of L-DHP or DL-DHP to stop the proliferation of fibroblasts and the
synthesis of collagen in lung parenchyma during paraquat intoxication.
The number of macrophages was reduced significantly (p<.05) by the
L-DHP treatment, but no differences were observed in the degree of
lung consolidation or mean alveolar wall thickening of the 3-paraquat-
dosed groups. This apparent lack of effect by L-DHP or DL-DHP on the
collagen-synthesizing fibroblasts is at variance with the observation
citing macrophages as the medium for fibroblast stimulation during
14
paraquat poisoning.
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Dehydroproline compounds minimized the destruction of type I
pneumocytes and the hyperplasia (increase) of type II pneumocytes.
QIC
Some investigators ' believe these are the basic pathological changes
in paraquat poisoning. On this basis, L-DHP gave some indication of
having reduced the degree of experimentally-induced paraquat lung
toxicity. The lesser effect of systemically administered paraquat
versus that of exposure to paraquat aerosol , may account for the
minimal pneumocyte effect observed following the subcutaneous paraquat
exposure of this report.
The lack of any significant difference, except marginal changes
on day 100 in macrophage number, number of pulmonary cells and alveolar
wall thickness in the DL-DHP treated group (Table 2), suggests that
pulmonary effects due to paraquat are initiated early in the syndrome.
These effects will only minimally improve with treatment over time,
once the changes are present. The observations after day 39 were
largely consistent with earlier observations before day 39. However,
the data presented here suggest that perhaps the response may have
been better had L-DHP been started within 1-4 days of paraquat exposure
instead of after 11 days post-paraquat exposure. The potential benefit
of DHP treatment should not be discarded until studies using more con-
current paraquat exposure and DHP treatment are carried out.
Under the conditions of this present study, there was insufficient
evidence to show that L-DHP or DL-DHP significantly decreased the pul-
monary fibrosis of experimental paraquat poisoning. However, the
observations do not rule out the possible value of DHP treatment if
16
given earlier in the paraquat toxicity syndrome. Further work needs to
be done to determine the pathogenesis of paraquat intoxication, since
pulmonary fibrosis and consolidation progressed in the face of DHP
therapy rather than diminishing as one would anticipate given the stated
mechanism of DHP on collagen synthesis.
17
FIGURE CAPTIONS
Fig 1--Structural formula for paraquat dichloride
Fig 2--Experimental design for the study of the effect of dehydroproline
(L-DHP or DL-DHP) on the response of rat lungs to paraquat ex-
posure. Groups are designated saline/saline, paraquat/L-DHP,
paraquat/DL-DHP and paraquat/saline.
Fig 3--Lung section from rat that received saline injection for 8 days
(Saline/Saline control group). Day 10. Alveolar walls normal
with little cellular infiltrates. X400.
Fig 4— Lung section from rat that received 7 mg paraquat/kg body weight
subcutaneously for 8 days (Paraquat/L-DHP). Day 10. Alveolar
wall thickness increased while number of the intra-alveolar
leucocytes/fibroblasts is decreased. X370.
Fig 5— Lung section from rat that received 7 mg paraquat/kg body weight
subcutaneously for 8 days (Paraquat/DL-DHP. Day 10. Alveolar
walls markedly increased in thickness. Infiltrating leucocytes/
2
fibroblasts are significantly decreased in number/0.08 mm of
lung sample. X400.
Fig 6--Lung section from rat that received 7 mg paraquat/kg body weight
subcutaneously for 8 days followed by 25 mg DL-DHP/kg body weight
for 14 days (Paraquat/DL-DHP group). Day 25. Marked increase in
the alveolar wall thickness and in consolidation. X350.
Fig 7--Lung section from rat that received 7 mg paraquat/kg body weight
subcutaneously for 8 days followed by daily saline injection for
14 days (Paraquat/Saline positive control group). Day 39.
18
Collapse of lung alveoli, thickening of the alveolar walls,
increased consolidation of the lung parenchyma, and marked
alveolar cellular infiltration by leucocytes/fibroblasts.
X350.
19
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APPENDIX I
A LITERATURE REVIEW OF PARAQUAT
AND RELATED CHEMICAL TOXICITIES
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CLINICAL SIGNS OF PARAQUAT POISONING
The initial signs of paraquat poisoning depend on the amount of
paraquat ingested. Ingestion of a massive dose (ie, more than 5 oz) of
the concentrated paraquat results in severe local irritation of the
mouth, pharynx, esophagus and stomach, accompanied by nausea, profuse
repeated vomition, and often abdominal cramps and diarrhea. Usually
this is accompanied by severe multisystem injury with total renal
shutdown and centrilobular necrosis of the liver. The victim may
become semi -comatose within a few hours of the ingestion; fatal pul-
monary edema may develop and death supervenes in a few days.
Ingestion of a lesser but potentially fatal amount (ie, less
than 0.5 oz) of the concentrated paraquat leads to nausea in the vic-
tim. Human victims may complain of a sore mouth and throat the day
after ingestion. The proper diagnosis may be missed altogether if a
history of paraquat ingestion is not available. By the second or third
day there may be clinical evidence of kidney and liver injury with
decreased urinary output and jaundice. Laboratory tests reveal rising
blood urea nitrogen and creatinine, and elevated serum transaminase
and bilirubin levels. With adequate treatment the kidney and liver
changes are reversible and non-fatal . However, the possibility of
death may be difficult for both the victim and the medical personnel
to accept, since clinical signs of impending respiratory failure may be
few or absent. Nevertheless, pulmonary function tests are likely "to
be abnormal and changes may also be visible in chest radiographs
(increased density of the lungs). Renal and hepatic function may
return to normal, but the victim develops increasing respiratory
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distress caused by progressive pulmonary fibrosis. Death ensues
within several days or weeks (1).
PATHOGENESIS OF PARAQUAT-INDUCED PULMONARY FIBROSIS
Fonowing ingestion and absorption of paraquat from the gastro-
intestinal tract, there is a heavy infiltration into the pulmonary
alveolar spaces of primitive connective tissue cells or profibro-
blasts. These profibroblasts undergo maturation into large basophilic
fibroblasts which occlude many alveolar spaces. Later, the alveolar
walls disintegrate, permitting the individual clumps of fibroblastic
tissue to coalesce, resulting in obliteration of the lung alveolar
architecture. The fibroblasts lay down a small quantity of collagen,
but death from respiratory failure usually occurs before this has
become extensive. This final stage of the disease (deposition of
collagen), is reminiscent of interstitial fibrosis of the lung, but
obliteration of the alveolar walls bellies its true intra-alveolar
origin.
It has been suggested that paraquat causes interstitial pul-
monary fibrosis simply by organization of inflammatory exudate (2).
Incorporation of organizing inflammatory exudate or cellular debris
into the alveolar walls can lead to interstitial fibrosis (3). How-
ever, chronic administration of paraquat to rats induces an extensive
fibrosis following only a slight fibrinous exudate (4,5). It has also
been shown that inhalation of paraquat aerosols by animals causes an
extensive exudation of fluid into the alveoli, but this does not result
in pulmonary fibrosis (5), It seems that the formation of a fluid
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exudate during the early stages of paraquat poisoning is not necessary
for the development of pulmonary fibrosis and that paraquat, or its
metabolities, directly stimulate the infiltration of profibroblasts
into the alveoli of the lungs. The experimental evidence from rats,
plus reported cases in man and domestic animals, suggests that the
pathogenesis of the paraquat lung is similar in all species. The
basic pathological change in the human and animal lung from paraquat
poisoning is a diffuse cellular, intra-alveolar fibrosis and not a
fibrosing alveolitis.
Caution must therefore be exercised in comparing the pathology of
experiments in control animals with those in human and domestic
animal disease, since those of human and domestic animals are often
modified by treatments such as oxygen therapy. In human cases in which
40% oxygen had been used, there was an early exudative phase charac-
terized by hyaline membranes, followed by a proliferative phase in
which there was a hyperplasia of granular pneumocytes and the develop-
ment of interstitial pulmonary fibrosis (7). In some cases (8) there
was also an intra-alveolar fibrosis. There is no doubt that paraquat
is capable of producing pulmonary fibrosis on its own, for intra-
alveolar fibrosis occurs when paraquat is given to rats breathing only
atmospheric oxygen; but one should consider the possibility that oxygen
toxicity may be a contributory factor in the pathogenesis of the pul-
monary fibrosis in some cases of paraquat poisoning in man and animals.
Furthermore, the histopathology of paraquat and oxygen poisoning is
somewhat different in that, although intra-alveolar fibrosis may occur
in the latter, there is always a prominent interstitial component in
-^IJT-,-
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the lungs (7). Further, there is no profuse hyperplasia of granular
pneumocytes in paraquat poisoning since most alveolar walls disinte-
grate and become engulfed by fibroblastic tissue.
SYNERGISM OF OXYGEN AND PARAQUAT IN PARAQUAT POISONING
Hypoxic treatment has been advocated in paraquat poisoning, since
oxygen and paraquat have a synergistic effect in producing lung injury
(9,10). In two of three cases of fatal paraquat poisoning reported
(11), victims were given oxygen in the course of their hospitalization.
In the first of these two cases, hypoxic treatment was given until life
could no longer be sustained without a high concentration of oxygen.
In the second case, paraquat poisoning was not suspected and the victim
received oxygen after the drop in arterial pO„. In both cases, it is
possible that the use of oxygen contributed in some degree to the for-
mation of the hyaline membranes and fibrosis seen histologically. The
victim in the third case did not receive oxygen, yet there was
beginning hyaline membrane formation. Except for superoxide dismutase
and immunosuppressive therapy, all other accepted therapeutic modali-
ties were used in these three lethal cases without positive results.
PATHOLOGIC FINDINGS IN PARAQUAT POISONING
IN HUMAN AND EXPERIMENTAL CASES
Paraquat is a potent multisystem poison for which no known anti-
dote has been discovered. The clinical effects of paraquat poisoning
seem to be dose-related. There is acute simultaneous multisystem fail-
ure with fatalities in a few days following ingestion of a large dose.
In smaller doses there is less severe, often transient involvement of
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the liver, kidneys, gastro-intestinal tract and progressively worsen-
ing, irreversible pulmonary fibrosis which leads to respiratory
insufficiency and death within a few weeks following ingestion.
The following pathologic findings were observed in three fatal
human cases of paraquat poisoning (11). In case 1, a 28-year-old
male orchard worker intentionally ingested 2.5 cups of 21% paraquat
solution, 40 Tylenol tablets, 10 asprin tablets and 20 pro-banthine
tablets. Jaundice, central and peripheral congestion, and edema were
noted at autopsy. There was congestion of the respiratory tree and
both the trachea and bronchi contained bloddy liquid. The lungs were
heavy, airless, markedly congested and edematous with focal areas of
hemorrhages. The liver Was soft and yellow. The mucosa and wall of
the stomach were edematous. The myocardium appeared light brown and
mottled. Histological examinations showed toxic myocarditis, conges-
tion, edema with focal hemorrhages, atelectasis and focal hyaline
membrane formation in the lungs. There was centrilobular necrosis of
the liver, and the kidneys had acute tubular necrosis. The adrenals
contained cortical necrosis with focal hemorrhages.
Case 2 followed intentional ingestion of 20% paraquat solution.
Treatment was started 18 hours after the ingestion. Post mortem find-
ings included intense icterus of the skin. The lungs were heavy,
airless, congested, edematous and had considerable fibrosis. The
bronchi contained blood-tinged mucous. There was marked enlargement
and greenish discoloration of the liver, and a section through it
showed a nutmeg pattern. The kidneys were also enlarged with marked
cortical congestion. Histopathological examination of the lungs
revealed congestion, edema, focal hemorrhages, marked intra-alveolar
3€
and interstitial pulmonary, fibrosis with a honeycomb appearance, and
foci of epithelial hyperplasia. The liver had congestion and centri-
lobular necrosis, focal erosive damage of the epithelium of the bile
ducts and mild periportal inflammation. There was acute tubular
necrosis of the kidneys with some regeneration.
In case 3, a 57-year-old male was admitted to the hospital
after several days of nausea, diarrhea, glossitis and pharyngitis with
a diagnosis of probably viral syndrome. X-rays revealed a worsening
pneumonitis. Paraquat poisoning was not suspected until shortly before
the patient's demise. Autopsy findings were heavy and airless lungs.
The pleural surfaces contained areas of fibrinous exudate and extensive
fibrous adhesions. There were also foci of pneumonia with mircoabscess
formation. Trachea and bronchi contained small amounts of bloody
mucoid material. The liver was greasy and enlarged. There was cardio-
megaly, and the cerebral hemispheres contained numerous petechial
hemorrhages within the white matter. The esophagus, stomach and
larynx had superficial focal erosions. Histological examination re-
vealed severe intra-alveolar and interstitital pulmonary fibrosis with
honeycombing, marked epithelial hyperplasia and squamous metaplasia
of the bronchial epithelium, pneumonia and abscess formation. There
was acute renal tubular necrosis with regeneration. Petechial hemor-
rhages of the brain were also observed, but the liver had minimal fatty
change. Myocardial necrosis, adrenal cortical necrosis and focal
esophageal, gastric and laryngeal erosions were minimal.
These cases illustrate the fatal outcome of large doses of paraquat
poisoning and the multisystem effects. The liver, kidneys, adrenals
and brain may become affected, but the fatal effect of paraquat
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poisoning tends to arise from respiratory insufficiency as a result of
intra-alveolar and interstitial fibrosis of the lungs. The cholangio-
cellular injury involving small and medium sized bile ducts has been
reported after paraquat ingestion (13). Paraquat is excreted into the
bile largely unchanged, and a possible reason for the bile duct injury
may be the local irritating effect of the compound (13). As a result
of biliary excretion of paraquat in a largely unchanged state, bile
may be successfully used to confirm the presence of paraquat.
Observations in experimental studies of paraquat poisoning using
rats (5,14) showed that large doses of paraquat administered to rats
caused central nervous derangements, particularly of locomotor activity.
The choking respiration with which these signs were associated may also
be the result of central neuropathy. However, the dyspnea which
developed was attributed to extensive alveolar edema following acute
paraquat intoxication. At this state of the disease, death was
presumably ascribed to the combined effects of central neuropathy and
acute respiratory failure.
Pulmonary fibrosis, which developed in rats after treatment with
paraquat, was demonstrated to originate from an infiltration into the
alveolar spaces of primitive mesenchymal cells, profibroblasts (5,14).
In an acute experiment, in which doses of up to 50-100 mg paraquat/kg
were used, dense cellular fibrosis with obliteration of alveolar
spaces was demonstrated. Electron microscopy showed this fibrosis
to be exclusively intra-alveolar in nature. The damage to the alveolar
walls was so severe that many were disruptured with just the cappil-
laries remaining intact. In the chronic experiments, the sequence of
changes leading to the maturation of profibroblasts into mature
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mature fibroblasts was traced. There was an initial loss of
pseudopodia of the profibroblasts and an increase in number and size
of mitochrondria. The rough endoplasmic reticulum became more exten-
sive. All of these changes resulted in the production of intermediate
forms, the elongation of which formed mature fibroblasts. Maturation
changes observed at the light microscopic level comprised a loss of
the "ragged" outline of primitive mesenchymal cells with an increase
in size and basophilia of the cytoplasm.
The development of this intra-alveolar fibrosis in the chronic
administration of paraquat was extremely rapid and death occurred
8 to 10 days after the onset of clinical signs. This rapid development
was explained to be due to a large number of infiltrating pro-
fibroblasts and the persistent supply of oxygen and nutrients to the
developing fibrous tissue (5). Although the reason for the formation
of the fibrosis in the first instance is not clear, it was suggested
that it arose simply by fibrous repair of damaged alveolar walls (2).
But this did not explain the origin of the intra-alveolar fibrosis.
Also, the destruction of the alveolar epithelium by chronic oxygen
poisoning produced only mild focal scarring and not the classic
florid fibrosis typical of paraquat poisoning in man (15). The fi-
brosis did not appear to develop from organization of an acute
inflammatory exudate since in a chronic experiment the inflammatory
reaction was mild and the alveoli contained little fribin.
Additionally, inhalation of paraquat aerosols produce more damage to
the alveolar epithelium than did systemic administration but pulmonary
fibrosis never resulted (6). It was reported that Conning and
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co-workers, in 1969, observed that paraquat actively stimulated
fibroblasts and that it achieved this through the medium of macro-
phages (14). The fact that paraquat produced pulmonary fibrosis only
when administered systematically, and that pulmonary fibrosis usually
developed after paraquat concentration in the body had dropped below
detectable levels, suggests that it is first metabolized in another
organ such as the liver (16). It appears that the acute phase of
paraquat poisoning, consisting of pulmonary edema and disintegration,
is not the necessary prerequisite for the development of subsequent
pulmonary fibrosis. In an experimental study, pulmonary fibrosis
developed from an intra-alveolar infiltration of pro-fibroblasts,
but where these cells come from still remains unknown (5). In the
early stages of chronic paraquat poisoning, many primitive mesenchymal
cells were observed in the vicinity of the bronchioles and blood
vessels. This observation was also described as an interstitial infil-
trate of primitive histiocyte-like cells which appeared to transform
into fibroblasts (2). It was suggested that these histiocytes origi-
nated from blood monocytes; however, no evidence of interstitial pro-
liferation or migration of histiocytes (ie, macrophages) was revealed
(5,14).
Investigation of the pathogenesis and structure of the paraquat-
exposed lung in rats found the presence of muscularized pulmonary
arterioles, suggesting that pulmonary hypertension had existed during
life (5). These hypertensive pulmonary arterioles were observed in a
chronic experiment in some rats with the most extensive pulmonary
fibrosis. It was theorized that these rats developed hypoxic hyper-
tensive pulmonary vascular disease secondary to fibrosis, in like manner
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as occurs in many human forms of pulmonary fibrosis (5),
In some of the rats in the chronic experiment foci of compact
interstitial fibrosis, patent alveoli, alveolar macrophages and a
continuous epithelial lining of granular pneumocytes existed. Why
such a lestion developed was unclear, although an identical histological
picture has been described in parts of the lungs of rats after prolonged
intoxication with Crotalaria spectabilis seeds (4). The significance of
these foci of pulmonary changes is not known but it is unlikely that they
play a major role in the paraquat-exposed lung.
TREATMENT AND MANAGEMENT OF PARAQUAT POISONING
The best course of management and treatment of cases of paraquat
poisoning is still debatable. Gastric lavage using Bentonite or
Fuller's earth has been tried to prevent further absorption of the com-
pound (17). Various techniques designed to eliminate paraquat from the
tissues include forced diuresis, hemodialysis, charcoal hemoperfusion,
and plasmapheresis (18). None of the elimination techniques are ^ery
effective. Some reports say that less than 2% of the estimated absorbed
dose can be removed by hemodialysis. Charcoal hemoperfusion has been
reported to be approximately five times more effective than hemodialysis
(19). Oxygen therapy has been reported to worsen the paraquat-induced
lung injury, thus hypo-oxygen treatment has been advocated (10). Based
on experimental data, treatment with superoxide dismutase (SOD) has been
advocated, since SOD is known to remove the superoxide radical Op , which
has been proposed as the toxic intermediary of paraquat poisoning (20).
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Immunosuppressive therapy has also been attempted (21). None of these
techniques is without some hazard to the patient, and the success rate
is, at best, modest.
Recent attempts at treatment of paraquat poisoning involved
surgical lung transplant in combination with injectable cyclosporine
over a long period of time to minimize the possibilities of tissue
rejection. There are attempts also in using inhibitors of collagen
synthesis, e.g., 3,4-DL-dehydroproline and 3,4-L-dehydroproline (22),
to treat paraquat poisoning in rats.
Modalities in the attempts to treat paraquat poisoning in man
and animals include the following:
(i) Use of antioxidants— Natural vit E and synthetic butyl-
hydroxyl toluene (BHT)
(ii) Use of clofibrate (ethyl -p-chlorophenoxyisobutyrate;
atromid-s)
(iii) Use of superoxide dismutase (SOD)
(iv) Hypoxic protection
(v) Use of N-acetyl-L-cysteine (NAC) •
(vi ) Use of niacin
Mechanism of Paraquat Poisoning and Vitamin E Therapy
Vitamin E . Since it has been established that paraquat functions
as a redox agent and contributes to the formation of oxygen free radicals,
many experiments have been conducted to explore mechanisms which might
reinforce their formation, accelerate their degradation to less to-xic
products, and interrupt the chain of reaction of lipid peroxidation
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through the use of antioxidants or free-radical scavengers.
The possible mechanisms of paraquat toxicity in mammals and how
they relate to therapy directed against the superoxide radical shows
that in the presence of reduced nicotinamide adenine dinucleotide
phosphate (NADPH) (Fig 1), paraquat can be reduced in a one-electron
transfer process by microsomal NADPH-cytochrome reductase. Paraquat
oxidation is coupled with the reduction of molecular oxygen resulting in
the formation of superoxide anion, singlet oxygen and possibly hydroxyl
radicals. These molecular species can react with polyunsaturated
fatty acids forming fatty acid free radicals and, with further oxidation,
lipid hydroperoxide radicals. The hydroperoxide radicals then maintain
the formation of new fatty acid radicals while being converted to
lipid peroxides in a chain reaction. Lipid peroxidation is destructive
to cell structure and function by damaging mitochondria, microsomal
organelles and other elements. The measuring of malondi aldehyde for-
mation has become a conventional procedure for monitoring lipid
peroxidation and hence confirming that paraquat causes lipid peroxi-
dation (23). Several enzymes are present in the cells that catabolize
the superoxide radical and reduce the lipid hydroperoxides to less toxic
lipid alcohols. The superoxide anions are converted to H^Op and 0^
by SOD, and the H^Op is further inactivated to H^O and O2 by the enzyme,
catalase. The reduction of lipid peroxides by glutathione peroxidase
requires reduced glutathione (GSH). Since the reduction of oxidized
glutathione is coupled with the oxidation of NADPH through glutathione
reductase, it does seem evidently that the availability of sufficient
NADPH is a critical factor for the detoxification process (24).
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Exposure of rats to high oxygen concentrations increases paraquat
mortality (9). In other experiments, low oxygen mixtures were shown
to reduce paraquat mortality and have lead to guidelines to limit
oxygen in poisoned patients. But because of the need for maintenance
of adequate peripheral oxygenation in the severaly affected patient
showing respiratory distress overrides these principles, oxygen is
usually administered. Although experimental studies using SOD seemed
to indicate that administration of the enzyme has protective effects,
clinical use of SOD has been disappointing (25). It is believed that
the inability of the protein molecule to penetrate cells, and its
rapid inactivation might be factors explaining its lack of significant
effect.
Since vitamin E is an antioxidant and hence acts as reducing sub-
stance and free-radical scavenger, it is rationalized that vitamin E
can quench superoxide radicals (26), and lipid-free radicals, thus
interrupting the chain reaction. Experimental studies demonstrated
greater paraquat mortality in mice maintained on a vitamin E deficient
diet than those receiving a vitamin E supplemented diet (27,28). The
possibility existed that vitamin E treatment, while not effective in
decreasing the acute death rate, could reduce the development of pul-
monary fibrosis in paraquat poisoning (24). The lack of an acute
beneficial effect of vitamin E further suggests that cellular NADPH
depletion rather than free radical mechanisms determine paraquat
toxicity.
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Butyl -hydroxyl toluene (BHT) . Paraquat appears to exert a toxic
activity only in the presence of oxygen. The free radical 0^ com-
pounds initiate an oxidative reaction in cell membranes and membranes
of the cytoplasmic organelles, so-called lipid peroxidation. This
action takes place especially in the lipid midzone of the membrane
containing chains of multiple unsaturated fatty acid (29).
If indeed paraquat poisoning is based on lipid peroxidation (30),
lipid-soluble antioxidants should be helpful in preventing signs of
intoxication. Consequently, the lipophilic synthetic antioxidant, BHT,
was tried as a potential antidote for paraquat poisoning (30), and the
following observations were made. The lipophilic antioxicant BHT
diminished mortality in rats intoxicated with paraquat. Post-mortem
histological examination also showed a favorable influence of BHT on
lung lesions. These findings support the hypotehsis that in paraquat
intoxication lipid peroxidation occurs and may be responsible for the
lung lesions. Whether BHT could be used as a therapy in human and
animal intoxications is still questionable in view of the observed BHT
toxicity in experiments where rats were pretreated with BHT before the
administration of paraquat (30).
Clofibrate
Clofibrate is used clinically as a preventative against premature
atherosclerosis and coronary heart disease (31). As a result of reported
increased hepatic antioxidant enzyme catalase activity following clifib-
rate treatment (32), clofibrate was tested for its effect on lung anti-
oxidant enzyme activity, and concurrently, as a possible protective agent
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for the paraquat-exposed lung (33). Since clofibrate could enhance
lung catalase and other antioxidant activity, it might have a pro-
tective action against paraquat-induced lung toxicity.
The clofibrate solution was administered either by subcutaneous
injection or by oral feeding with stomach tube in a dose of 0.5 ml/
100 g body weight. Clofibrate was diluted to a concentration of
12 mg/ml and preadministered before the dose of 35 mg paraquat/kg
was given. Only 28% and 29% of the untreated controls were alive
10 days post-paraquat as opposed to 70% of the clofibrate-pretreated
animals (33). The paraquat-exposed rats had extensive perivascular
edema and localized areas of intra-alveolar edema and/or hemorrhages,
whereas the rats pretreated with clofibrate showed minimal or no peri-
vascular fluid accumulations and no areas of intra-alveolar edema or
hemorrhages. No significant changes in catalase activity or any other
potentially protective lung enzymes were found. It appeared that clo-
fibrate's protective action against paraquat was not due to its
augmentation of these lung defenses against O2" free radical (paraquat)
injury.
In other experiments in which clofibrate was administered after
the lethal dose of paraquat (instead of the pretreatment regimen), the
10-day survival rate was no different in the clofibrate-treated animals
versus the paraquat control rats. While it is unfortunate that clo-
fibrate administration after paraquat was not protective against
paraquat-induced lung toxicity, if the protective mechanism of the pre-
treatment regimen can be unraveled, it may provide valuable clues to
suggest effective post-paraquat treatment approaches (33).
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Superoxide Dismutase (SOD)
Paraquat has a low reduction potential and if reduced can
utilize molecular oxygen as a one-electron acceptor (34). Diquat
(l,l'-ehtylene-2,2'dipyridylium dichloride), an analogue of paraquat
was found to produce superoxide free radicals (Op") when reduced
aerobically by NADPH and glutathione reductase or photochemical ly in
the presence of EDTA (25). The production of OA" free radicals was
inhibited by SOD, an enzyme existing in all oxygen-utilizing cells and
which is known to remove 02"'+2H » H^Op; SOD is thought to be the
primary defense against the potential damage to cells from free-radical
species. These considerations suggest that the administration of SOD
to animals intoxicated with paraquat might exert a protective effect
against paraquat toxicity.
Several experiments conducted in this field (25) revealed the
following: (i) There was a delay of several hours before death super-
vened in paraquat-treated rats treated with SOD when compared to
paraquat-treated rats which did not receive SOD; (ii) Although areas
of hypercullularity were observed after treatment with paraquat and
SOD, the areas of cellular infiltration were much more reduced and
the retention of extensive areas of normal alveolar structure much
greater when compared with the lungs of those animals which did not
receive the enzyme treatment.
By the method of grid-overlay, in which unit areas of normal
alveolar structure and of hypercellularity or inflammation were
counted and compared, analysis showed the percentage of abnormal
alveolar structure within the total field of the lung section from
the paraquat-treated rat was almost three times that of the controls.
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The value obtained upon similar analysis of the lung tissue from the
SOD and paraquat-treated animals was one-half of the value obtained
from the animals treated with paraquat along (25):
Rat Treatment Abnormal Alveolar Structure {%)
Air 24
Air + Paraquat 70
Air + Paraquat + SOD 35
SOD extended by more than two-fold the lifetime of animals
treated with paraquat and maintained in air. SOD also reduced the
microscopically-observable damage in lung tissue of these rats.
Such modest response of the paraquat-exposed lung in rats to SOD
therapy (25) may be useful in combination with other therapeutic
procedures in the treatment of pulmonary fibrosis caused by paraquat
poisoning in man and domestic animals.
Hypoxic Protection
Since its introduction as a herbicide in 1962, paraquat has
caused the death of more than 120 individuals. Fatalities were due
to accidental or intentional ingestion, rather than by inhaling the
aerosol (5). But regardless of the route of administration, the lungs
are the major site of pathologic changes caused by paraquat.
Paraquat toxicity in both plants and animals is believed to be
mediated by the ability of this chemical to accept electrons from cell
components, eg, flavo-proteins or chlorophyll, and to transfer these
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electrons directly to molecular oxygen. This single-electron transfer
leads to formation of superoxide radicals which peroxidize membrane
lipids and enzymes, thus disrupting normal metabolic pathways (10).
Investigators (35), quoting their earlier work, believed that the
superoxide radical may play an important role in the pathogenesis of
oxygen toxicity. Another work (9) pointed out that the pulmonary
pathological changes induced by paraquat in many ways resembled those
of oxygen toxicity. This study reported that Escherichia coli
grown aerobically was inhibited by paraquat, whereas E_. coli grown
anaerobically was not affected by paraquat, indicating the importance
of the ambient oxygen concentration on paraquat toxicity (9).
Due to reports of accelerated paraquat toxicity in elevated
oxygen concentration, experimental studies showed a protective effect
of hypoxia on paraquat toxicity, and a decreased cumulative mortality
rate of mice parenterally injected with paraquat (10). This protective
effect of hypoxia may simply be due to lowering of the concentration of
one of the constituents of the toxic chemical reaction. The lungs and
in particular the alveolar epithelia are the primary target (10) for
the following reasons:
(i) The alveolar pO^ was higher than in any other part of the
body; and
(ii) Paraquat was concentrated in the lung.
Paraquat poisoning is not the only form of pulmonary insult
aggravated by increased levels of oxygen. Viral and pneumonococcal
infection, nitrogen dioxide exposure, and intravenous oleic acid
toxicity are increased by supplemental oxygen exposure (36). The-
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lung was reported to tolerate hypoxia better than hyperoxia (37).
A protective effect of hypoxia was implicated in reducing hyaline
membrane changes of the lungs, but there was no change in the mor-
tality rate (38).
N-Aceytl-L-cysteine (NAC)
Evidence of lipid peroxidation by paraquat in pulmonary tissue
has been demonstrated (27). In paraquat poisoning, the redox reac-
tions which occur lead to the formation of lipid hydroperoxides by
peroxidation of polyunsaturated membranes by dismutating singlet
oxygen. Antioxidants, such as vitamin E, are presumed to terminate
the chain reaction of lipid peroxidation (24). The lipid hydro-
peroxides are finally reduced by gluthathione peroxidase to less toxic
lipid alcohols by oxidizing reduced glutathione (GSH) and hence
preventing lipid free radicals that lead to membrane damage (Fig 2).
There is a decrease in GSH in the liver in acute paraquat
poisoning (28) indicating an important role in reducing hydroperoxide
formation (Fig 1); therefore, significant depletion of GSH enhances
paraquat toxicity. On the other hand, replenishing glutathione exo-
genously has not proved effective in diminishing the toxicity because
GSH does not penetrate cell membranes readily (27,28), It is, however,
proposed that NAC can serve as a source for replenishing GSH from
its oxidized form and thus accelerates the conversion of the toxic
lipid hydroperoxides to less toxic lipid alcohols.
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Niacin
Niacin is beneficial to rats poisoned by paraquat (39). This
finding was developed from earlier works which disclosed that the
common sites of damage are at the enzyme level in bacteria poisoned
by paraquat and by hyperbaric oxygen. The evidence included the
discovery that niacin and thiamine were beneficial for the growth of
£. coli poisoned by hyperbaric oxygen or by paraquat. The mechanism
of thiamine protection remains unknown, but there is evidence that
niacin protects E. coli because it circumvents the consequences of
the poisoning of quinolinate phosphoribosyl transferase. This enzyme
is required for the de novo synthesis of nicotinamide adenine dinculeo-
tide (NAD). This led to the belief that the results may apply to
higher life forms.
From experimental results (39), niacin-treated rats showed delayed
and reduced dyspnea, and the death rate was reduced from 75% to 55%.
The benefit of niacin is consistent with the demonstrated role of
niacin in preventing cellular decreases of NAD during poisoning of bac-
teria by paraquat and by hyperbaric oxygen.
NATURE OF COLLAGEN
Collagen is a fibrous protein which is composed of individual
polypeptides which are often laterally cross! inked by several types
of bonding. Because of their structure, they are physically tough
and water insoluble, valuable properties for their role as structural
elements of tissue. Collagen, unlike other fibrous proteins, has no
<<-helix because of its high content of glycine (25%) and proline and
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hydroxyproline (25% combined). However, since these particular amino
acids occur with repeated regularity in the sequence, the polypeptide
chains are wrapped around each other in cable fashion and crosslinked
by hydrogen bonding to form tropocollagen, the basic structural unit
of collagen.
THE EFFECTS OF INHALATION OF PARAQUAT
Exposure of rats to aerosols of paraquat containing over 80%
droplets in the size range of 2.5— 5Aim produced pathological
changes in lungs (6). Pulmonary epithelium was damaged, and there
were pulmonary capillary congestion, extensive alveolar edema, fibrin
and hemorrhages following aerosol izations. The rats usually made a
complete recovery if death did not supervene three days after the ex-
posure. It was impossible to produce pulmonary fibrosis by respirable
aerosols of paraquat despite the extensive pulmonary damage (6).
In a further investigation (40), paraquat was tracheally instilled
into rats using Indian ink marker. Only localized fibrosis and epi-
thelial proliferation was described; the rest of the lungs remained
normal
.
METHODS OF PARAQUAT AND DIQUAT ASSAY
The concentration of the bipyridyls in the blood and urine of
paraquat-exposed patients is used to estimate the dose and the rate
of clearance from the body. A method of assaying paraquat and diquat
utilizes their colored stable free-radicals (16). In this technique,
measured quantity of urine from a paraquat patient is diluted to
50 ml with water and the protein is precipitated by adding
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trichloroacetic acid. This mixture is centrifugated and the pellet
is re-extracted with trichloroacetic acid. The supernatant of both
solutions is pooled and passed through a cation exchange resin. For
paraquat the resin is left in its hydrogen form, while the column is
converted to a sodium form for diquat by washing with sodium chloride.
The bipyridyls are eluted from the column by a mixture of 5 ml ammonium
chloride and 1 ml freshly prepared sodium dithionite. Then 1 N sodium
hydroxide is added to the eluate. This reduces the bipyridyl ion to
its colored radical. Using a light wave length of 600 nm, the optical
absorbance of the colored solution can be measured spectrophometrically.
This is then compared with calibration graphs prepared from standard
solutions. As little as 3 ug diquat and 10 ug paraquat may be detected
by this method.
A similar and faster method of assay can be carried out in which
2 ml of 1% sodium dithionite in 1 N sodium hydroxide is added to
10 ml of urine. A blue coloration detectable with the naked eye is
indicative of the presence of the bipyridyls.
These two techniques have been applied to measure the concentration
of paraquat in the blood and urine of human cases of paraquat poisoning
and hence to calculate the amount of paraquat excreted daily.
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Fig 1. Proposed mechanism of action for the in vivo toxicity of
paraquat in which paraquat is reduced by microsomal NADPH-
cytochrome reductase (27).
Fig 2. Proposed role of N-acetyl-L-cysteine (NAC) in the reduction
of paraquat poisoning. Adapted from Bus et al (27).
PUFA = Polyunsaturated Fatty Acid.
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APPENDIX II
TREATMENT OF RATS WITH PARAQUAT AND/OR THE
COLLAGEN INHIBITORS L-3,4-DEHYDR0PR0LINE (L-DHP) AND
DL-3,4-DEHYDR0PR0LINE (DL-DHP)
(A review and summary of the previous studies of F. Akahori and
F.W. Oehme: Inhibition of Collagen Synthesis as a Treatment for
Paraquat Poisoning. Vet Hum Toxicol 25:321-327, 1983.)
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In a preliminary study male Sprague-Dawley rats were used. Nine
groups of six rats each (54 total) were exposed to varying doses of
paraquat (1 mg/kg to 50 mg/kg body weight) subcutaneously to determine
the dose effective in producing pulmonary fibrosis. This study es-
tablished that 7 mg/kg of paraquat dichloride solution given subcutane-
oulsy for 7 or 8 days was needed to initiate pulmonary fibrosis. The
loss in body weight of the rats and the increase in lung hydroxproline
content were the criteria for this determination; when a decrease in
body weight was observed paraquat administration was discontinued.
Of a total of 134 previously untreated rats, 31 received 1.4 ml/kg
body weight of sterile saline solution and 103 rats received 7 mg para-
quat/kg body weight for 7 or 8 days (Fig. 1). All the doses were given
subcutaneously. Ten days after the start of paraquat dosing (day 10),
paraquat-dosed group of rats was divided randomly into three groups to
receive L-3,4-dehydroproline (L-DHP) or DL-3,4-dehydroproline (DL-DHP)
or saline; 34 rats received 25 mg L-DHP/kg/day, 34 rats received 25 mg
DL-DHP/kg/day, and 35 rats received 1.4 ml sterile saline/kg/day, each
for 14 consecutive days (days 11-24). The saline-dosed' group of rats
also received saline injection subcutaneously from days 11-24 of the
103 rats that received paraquat, 31 died within days 11-24 — 13 in
the paraquat/L-DHP group, 9 in the paraquat/DL-DHP and 9 in the para- .
quat/saline group.
Rats from the various groups (saline/saline, paraquat/L-DHP,
paraquat/DL-DHP, paraquat/saline) were sacrificed on days 10, 18, 25,
32, 39 and 100 after the paraquat dosing was stopped for the determi-
nation of lung and heart weights, total lung protein and collagen
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content of the lung and to collect lung tissues for histopathology.
Sacrifice was induced using methoxyflurane and the rats were drained
of blood via the abdominal aorta. The lung, blood and heart samples
were preserved by rapid freezing in liquid nitrogen for biochemical
analysis while the right posterior caudal lobe of the lung was fixed
in formalin for later morphometric histopathology.
An increase in the body weights of paraquat- treated rats from day
25 to day 39 was observed. Paraquat/L-DHP and paraquat/DL-DHP-treated
groups gained slightly more weight than the paraquat/saline-treated
group between days 32 and 39. This difference was not statistically
significant. The mean lung wet weight of the rats that gained weight
was not statistically significant between groups. However, the lung
wet weight to body weight ratios in the paraquat-treated animals whose
weight decreased was statistically significant at the 1% and 5% level
on days 10 to 39. No significant differences were observed in the
heart weights of all the groups of rats. The lung total protein
concentrations in the paraquat-treated groups increased significantly
(at the 5% level). The total lung collagen of the paraquat-treated
rats, expressed as umol of hydroxyproline per rat, was significantly
increased (at the 1% level) on day 10. Collagen accumulation in the
lungs of the paraquat/saline-treated rats was significantly higher
(at the 1% and 5% level) during the 39 days of observation. L-DHP
orDL-DHP administration did not significantly block the rise in lung
collagen content as shown by comparing paraquat-treated rats which did
not receive L-DHP or DL-DHP (paraquat/saline) to those that did. All
paraquat-dosed rats had markedly increased lung collagen levels compared
to the saline-dosed animals (saline/saline group). The lung collagen
content of rats treated with DL-DHP (paraquat/DL-DHP) was less elevated
than in the rats that did not receive DL-DHP (paraquat/saline). This
difference, however, was not statistically significant. No paraquat-
induced pulmonary fibrosis was fatal during day 39-100.
The effect of L-DHP or DL-DHP on inhibition of lung collagen syn-
thesis was not significant. These "antidotes" failed to alter pulmonary
fibrosis resulting from paraquat expsoure and intoxication to rats.
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APPENDIX III
INDIVIDUAL RESULTS OF RAT LUNG MORPHOMETRIC MEASUREMENTS
67
FIGURE CAPTIONS
Fig 1 -- Extensive collapse of lung alveoli and marked consolidation
of parenchyma. Paraquat/Saline Group. Day 10. Mag x 330.
Fig 2 -- Average number of intra-alveolar macrophages on various days
after initiation of paraquat dosing.
Fig 3 -- Average number of mononuclear cells on various days after
initiation of paraquat dosing.
Fig '4 -- Average number of total pulmonary cells on various days after
paraquat dosing was initiated.
Fig 5 -- Mean alveolar wall thickness [jdm] on various days after para-
quat dosing was initiated.
Fig 6 — Average lung consolidation (%) on various days after paraquat
dosing was initiated.
Fig 7 -- Type I pneumocytes (%) on various days after paraquat dosing
was started.
Fig 8 -- Type II pneumocytes (%) on various days after paraquat dosing
was started.
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Average Number of Total Pulmonary Cells/0.08 mm^
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Average Lung Consolidation (%)
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Paraquat is a non-selective herbicide, expsoure to which has been
associated with animal and human deaths. The most devastating effect
of paraquat poisoning is the exudation of edema fluid and hemorrhages
into the lung parenchyma. If the victim survives these initial effects,
a fulminating fibrotic process develops and death results from anoxia
due to progressive pulmonary fibrosis. Paraquat poisoned rats have in-
creased lung levels of hydroxyproline and prolyl -hydroxylase, and an
increased rats of collagen synthesis leading to pulmonary fibrosis. The
proline analogue dehydroproline (DHP) inhibits the biosynthesis and
secretion of collagen by competitively blocking the aminoacylation of
t-RNA by proline. DHP also inhibits prolyl -hydroxylase activity. Be-
cause of these effects on collagen biosynthesis, DHP was studied as an
antidote for experimental paraquat poisoning in rats.
Preliminary studies determined that the subcutaneous administration
of 7 mg paraquat/kg body weight for 7-8 days was an appropriate dosage
for this study. A decrease in the body weight of the rats between
days 1 and 10 after paraquat dosing was started, was used to detect
rats in which paraquat had induced pulmonary fibrosis. L-DHP or DL-DHP
at a dose rate of 25 mg/kg body weight or saline at a dose rate of
1.4 ml/kg body weight was then administered subcutaneously to groups of
the paraquat-dosed rats for 14 days (day 11-24). One group of rats
that earlier received no paraquat, but only saline, was treated with
saline for 14 days as a negative control group. Representative numbers
of rats from each group were sacrificed on days 10, 18, 25, 32, 39 and
100. Lung tissue was collected and fixed in formalin for histopatho-
logical preparation. Morphometric histopathological measurements and
analysis were applied to the following parameters under light micro-
scopy: number of intra-alveolar macrophages and leucocytes, total
number of pulmonary cells, mean alveolar wall thickness, percent
consolidation of lung parenchyma and the relative number of various
cell types (type I and type II pneumocytes). The results were com-
pared between the various groups using two-way analysis of variance.
Although statistical analysis of the various parameters showed
no improvement of pulmonary fibrosis or consolidation with DHP
treatment after paraquat intoxication, DHP did significantly reduce
the total number of pulmonary cells, especially the number of macro-
phages. If stimulation of fibroblastic activity is through the medium
of macrophage number, DHP may have in this sense decreased the lung
response to paraquat exposure. However, the administered DHP did not
reduce the accompanying pulmonary consolidation and fibrosis.
